Logo image of HKPD

HONG KONG PHARMA DIGITAL TEC (HKPD) Stock Fundamental Analysis

USA - NASDAQ:HKPD - KYG6365B1041 - Common Stock

1.4 USD
-0.31 (-18.13%)
Last: 10/24/2025, 8:00:01 PM
1.44 USD
+0.04 (+2.86%)
After Hours: 10/24/2025, 8:00:01 PM
Fundamental Rating

0

Overall HKPD gets a fundamental rating of 0 out of 10. We evaluated HKPD against 23 industry peers in the Air Freight & Logistics industry. HKPD may be in some trouble as it scores bad on both profitability and health. HKPD is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

HKPD Yearly Net Income VS EBIT VS OCF VS FCFHKPD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2024 2025 0 500K 1M 1.5M

1.2 Ratios

HKPD has negative profitability rations, so we won't be analyzing them here.
Industry RankSector Rank
ROA N/A
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
HKPD Yearly ROA, ROE, ROICHKPD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2024 2025 0 10 20 30

1.3 Margins

HKPD does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
HKPD Yearly Profit, Operating, Gross MarginsHKPD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2024 2025 0 5 10 15 20

More info and screens

0

2. Health

2.1 Basic Checks

HKPD does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for HKPD remains at a similar level compared to 1 year ago.
Compared to 1 year ago, HKPD has a worse debt to assets ratio.
HKPD Yearly Shares OutstandingHKPD Yearly Shares OutstandingYearly Shares Outstanding 2024 2025 2M 4M 6M 8M 10M
HKPD Yearly Total Debt VS Total AssetsHKPD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2024 2025 2M 4M 6M 8M

2.2 Solvency

Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z N/A
ROIC/WACCN/A
WACC8.01%
HKPD Yearly LT Debt VS Equity VS FCFHKPD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2024 2025 0 1M 2M 3M 4M

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
HKPD Yearly Current Assets VS Current LiabilitesHKPD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2024 2025 2M 4M 6M 8M

More info and screens

0

3. Growth

3.1 Past

EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
HKPD Yearly Revenue VS EstimatesHKPD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2024 2025 5M 10M 15M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

Industry RankSector Rank
PE N/A
Fwd PE N/A
HKPD Price Earnings VS Forward Price EarningsHKPD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
HKPD Per share dataHKPD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for HKPD!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

HONG KONG PHARMA DIGITAL TEC

NASDAQ:HKPD (10/24/2025, 8:00:01 PM)

After market: 1.44 +0.04 (+2.86%)

1.4

-0.31 (-18.13%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupTransportation
GICS IndustryAir Freight & Logistics
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners0.67%
Inst Owner ChangeN/A
Ins Owners16.33%
Ins Owner ChangeN/A
Market Cap15.40M
Revenue(TTM)N/A
Net Income(TTM)N/A
AnalystsN/A
Price TargetN/A
Short Float %10.45%
Short Ratio0.1
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)N/A
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpSN/A
BVpSN/A
TBVpSN/A
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA N/A
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset TurnoverN/A
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-ScoreN/A
WACC8.01%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A

HONG KONG PHARMA DIGITAL TEC / HKPD FAQ

What is the fundamental rating for HKPD stock?

ChartMill assigns a fundamental rating of 0 / 10 to HKPD.


Can you provide the valuation status for HONG KONG PHARMA DIGITAL TEC?

ChartMill assigns a valuation rating of 0 / 10 to HONG KONG PHARMA DIGITAL TEC (HKPD). This can be considered as Overvalued.


How profitable is HONG KONG PHARMA DIGITAL TEC (HKPD) stock?

HONG KONG PHARMA DIGITAL TEC (HKPD) has a profitability rating of 0 / 10.


What is the financial health of HONG KONG PHARMA DIGITAL TEC (HKPD) stock?

The financial health rating of HONG KONG PHARMA DIGITAL TEC (HKPD) is 0 / 10.